151 related articles for article (PubMed ID: 38467341)
1. The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study.
Torii A; Oki M; Iida H; Yamada A; Kogure Y; Kitagawa C; Saka H
Pulm Pharmacol Ther; 2024 Jun; 85():102297. PubMed ID: 38467341
[TBL] [Abstract][Full Text] [Related]
2. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract][Full Text] [Related]
4. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
Satou A; Tsuzuki T; Nakamura S
J Clin Exp Hematop; 2019; 59(2):56-63. PubMed ID: 31257346
[TBL] [Abstract][Full Text] [Related]
5. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system other iatrogenic immunodeficiency-associated lymphoproliferative disorders presenting as extraosseous plasmacytoma with a progressive clinical course: A case report and literature review.
Ohgaki F; Takemoto Y; Paku S; Tatezuki J; Kumagai J; Shuto T; Mochimatsu Y
Neuropathology; 2023 Apr; 43(2):151-157. PubMed ID: 36065518
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders With Multiple Oral Mucosal Lesions During Methotrexate Therapy.
Hayashi I; Toida M
Cureus; 2024 Apr; 16(4):e58995. PubMed ID: 38800284
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
10. Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Yasuda H; Ando J; Yoshida S; Ota Y; Komatsu N; Ando M
Intern Med; 2023 Feb; 62(4):601-604. PubMed ID: 35793959
[TBL] [Abstract][Full Text] [Related]
11. [Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Tokuhira M; Kizaki M
Rinsho Ketsueki; 2019; 60(8):932-943. PubMed ID: 31484893
[TBL] [Abstract][Full Text] [Related]
12. [Four Cases of Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders in the Head and Neck Region].
Fukasawa M; Akazawa Y; Kasugai S; Mikami K; Saito Y; Akutsu M; Akashi A; Ido K; Maeda I; Hoshikawa M; Koizuka I
Nihon Jibiinkoka Gakkai Kaiho; 2016 May; 119(5):741-9. PubMed ID: 27459820
[TBL] [Abstract][Full Text] [Related]
13. Rare Oral Presentation of a Mycophenolate Mofetil-Related Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder (MMF-OIA-LPD) Lesion: A Case Report and Literature Review.
Taliaferro A; Samhouri Y; Rice J; Khan CM; Cillo JE
J Oral Maxillofac Surg; 2021 Feb; 79(2):398-403. PubMed ID: 32916134
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate‑related other iatrogenic immunodeficiency‑associated lymphoproliferative disorder in the CNS and medication‑related osteonecrosis of the jaw occurring simultaneously: A case report.
Kato T; Mizumoto C; Inoue F; Watanabe T; Yamanaka S; Fukuhara S; Nakao K
Exp Ther Med; 2024 Jan; 27(1):41. PubMed ID: 38125353
[TBL] [Abstract][Full Text] [Related]
15. Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder Presenting as Primary Bone Lymphoma in a Patient with Rheumatoid Arthritis.
Ishiguro K; Hayashi T; Aoki Y; Murakami R; Ikeda H; Ishida T
Intern Med; 2016; 55(16):2259-64. PubMed ID: 27523005
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
[TBL] [Abstract][Full Text] [Related]
17. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
[TBL] [Abstract][Full Text] [Related]
18. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders in a patient with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: A case report and systematic literature review.
Nishimura N; Niwamoto T; Arai Y; Nakashima R; Terada K; Yoshizawa A; Sakamoto R; Tanizawa K; Handa T; Morinobu A; Hirai T
Int J Rheum Dis; 2023 Jun; 26(6):1172-1177. PubMed ID: 36789793
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
Satou A; Banno S; Kohno K; Takahara T; Takahashi E; Nobata H; Iwagaitsu S; Watanabe D; Hanamura I; Takami A; Ito Y; Nakamura S; Tsuzuki T
Pathology; 2021 Aug; 53(5):595-601. PubMed ID: 33618861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
